Saluda

Judah VanSyckel Named 2021 Legal Elite by Columbia Business Monthly for Three Categories

Retrieved on: 
Tuesday, August 3, 2021

LEXINGTON, S.C., Aug. 3, 2021 /PRNewswire/ -- Saluda Law is proud to announce that Attorney Judah VanSyckel has been named by Columbia Business Monthly as one of the 2021 Legal Elite in South Carolina for the Corporate Investigations, Healthcare, and Criminal categories.

Key Points: 
  • LEXINGTON, S.C., Aug. 3, 2021 /PRNewswire/ -- Saluda Law is proud to announce that Attorney Judah VanSyckel has been named by Columbia Business Monthly as one of the 2021 Legal Elite in South Carolina for the Corporate Investigations, Healthcare, and Criminal categories.
  • Mr. VanSyckel is thankful to have been recognized by the Columbia Business Monthly and other South Carolina Attorneys for his work in these areas.
  • A former healthcare fraud prosecutor, Mr. VanSyckel's practice areas include criminal defense , whistleblower matters , and healthcare matters.
  • Mr. VanSyckel would like to thank his clients for the trust that they have placed in him over the years with their legal needs.

Artis Closes $7 Million Series A Funding Round Led by Saluda Grade

Retrieved on: 
Wednesday, July 21, 2021

Saluda Grade is one of the leading innovators and investors in the alternative non-bank lending sector.

Key Points: 
  • Saluda Grade is one of the leading innovators and investors in the alternative non-bank lending sector.
  • Brad Hartung, Portfolio Manager at Saluda Grade, commented, Artis provides a cutting-edge technology solution to a broken and outdated point of need lending landscape.
  • The team at Artis has proven an ability to execute their vision, and Saluda Grade is excited to marry our capital markets expertise and execution to accelerate their growth.
  • Morris, Manning, and Martin, LLP advised Artis in closing this Series A funding round.

Saluda Law, LLC Announces Opening of Second Office in McCormick, South Carolina

Retrieved on: 
Thursday, June 24, 2021

MCCORMICK, S.C., June 24, 2021 /PRNewswire/ --Saluda Law, LLC is proud to announce the opening of the firm's second location in McCormick, South Carolina.

Key Points: 
  • MCCORMICK, S.C., June 24, 2021 /PRNewswire/ --Saluda Law, LLC is proud to announce the opening of the firm's second location in McCormick, South Carolina.
  • Attorney Judah VanSyckel of Saluda Law states, "It's exciting to be able to open this new office to provide services to the people of one of the historically underserved rural communitiesin South Carolina."
  • Saluda Law, LLC looks forward to continuing to partner with local organizations as part of the firm's commitment tothe community.
  • Attorney Judah VanSyckel of Saluda Law, LLC
    Photo of Judah VanSyckel of Saluda Law, LLC.

Saluda Grade Taps Securitization Market Again with FIGURE HELOC Deal

Retrieved on: 
Tuesday, March 9, 2021

The transaction, GRADE 2021-FIG2, closed on February 26th and is the fifth securitization issued and sponsored by an SGAM-managed fund.

Key Points: 
  • The transaction, GRADE 2021-FIG2, closed on February 26th and is the fifth securitization issued and sponsored by an SGAM-managed fund.
  • The deal also marks the second time the two companies have come to market in six months.
  • Figure Technologies, Inc., a portfolio investment held in a fund of Saluda Grade Ventures ("SGV") 1, the venture arm of Saluda Grade, has worked closely with the Saluda Grade Advisory ("SGA") team to access more scalable capital through institutional partners.
  • "This transaction further cements our ability to execute as both an equity partner and capital markets provider within the platform2 we have created at Saluda Grade," said Ryan Craft, CEO of Saluda Grade.

Saluda Medical Announces Executive Leadership Changes

Retrieved on: 
Friday, February 12, 2021

ARTARMON, Australia, Feb.12, 2021 /PRNewswire/ --Saluda Medical Pty Limited ("Saluda Medical"), the market leader in the development of novel closed-loop spinal cord stimulation (SCS) for the treatment of chronic pain, today announced the appointment of Jim Schuermann as President & Chief Executive Officer.

Key Points: 
  • ARTARMON, Australia, Feb.12, 2021 /PRNewswire/ --Saluda Medical Pty Limited ("Saluda Medical"), the market leader in the development of novel closed-loop spinal cord stimulation (SCS) for the treatment of chronic pain, today announced the appointment of Jim Schuermann as President & Chief Executive Officer.
  • Mr. Schuermann joined Saluda Medical as President in June 2020.
  • This realignment in leadership comes as Saluda Medical advances its pipeline of spinal cord stimulation innovation and continues toward global commercialization and pursuing FDA approval.
  • Saluda Medical is a global neuromodulation company leading the development and commercialization of data-driven, personalized therapies for patients with chronic pain.

AlphaFlow Announces $10 Million Series A Funding Round Led by Saluda Grade Ventures

Retrieved on: 
Thursday, November 12, 2020

AlphaFlow , the leading institutional platform for investing online in real estate debt, today announced a $10 million Series A funding round led by Saluda Grade Ventures .

Key Points: 
  • AlphaFlow , the leading institutional platform for investing online in real estate debt, today announced a $10 million Series A funding round led by Saluda Grade Ventures .
  • Ryan Craft, founder & CEO of Saluda Grade, led the investment and will take a seat on AlphaFlows board.
  • Additionally, Y Combinator, 10X Capital, Resolute Ventures, Upside Partnership, Vishal Garg (CEO of Better Mortgage), Gokul Rajaram, and other notable investors participated in the round.
  • Previous funding also included Social Capital, Clocktower Ventures, and Point72 Ventures.

Saluda Medical Appoints Jim Schuermann as President and Robert Gaffney as Chief Operating Officer

Retrieved on: 
Tuesday, June 9, 2020

ARTARMON, Australia, June 9, 2020 /PRNewswire/ --Saluda Medical Pty Limited ("Saluda Medical"), a global neuromodulation company leading the development and commercialization of data-driven, personalized therapies for patients with debilitating neurological disorders, today announced the key leadership appointments of Jim Schuermann as President and Robert Gaffney as Chief Operating Officer.

Key Points: 
  • ARTARMON, Australia, June 9, 2020 /PRNewswire/ --Saluda Medical Pty Limited ("Saluda Medical"), a global neuromodulation company leading the development and commercialization of data-driven, personalized therapies for patients with debilitating neurological disorders, today announced the key leadership appointments of Jim Schuermann as President and Robert Gaffney as Chief Operating Officer.
  • As President, Mr. Schuermann will be responsible for the global commercial and clinical strategy and execution of corporate objectives.
  • John Parker, CEO of Saluda Medical, commented, "Jim and Bob bring to Saluda a wealth of knowledge, experience, and successful track records.
  • Mr. Schuermann brings over 25 years of extensive healthcare and medical device leadership experience to Saluda Medical.

Saluda Grade Raises $20 Million For Alternative Lending Growth Equity Fund

Retrieved on: 
Thursday, April 16, 2020

NEW YORK and SAN FRANCISCO, April 16, 2020 (GLOBE NEWSWIRE) -- Saluda Grade Ventures, a private alternative real estate finance venture firm, announced today that it has raised more than $20 million for its debut growth equity fund.

Key Points: 
  • NEW YORK and SAN FRANCISCO, April 16, 2020 (GLOBE NEWSWIRE) -- Saluda Grade Ventures, a private alternative real estate finance venture firm, announced today that it has raised more than $20 million for its debut growth equity fund.
  • The Saluda Grade Alternative Lending & Fintech Growth Fund I invests in elite alternative non-bank lenders, including private real estate lenders, technology-forward lending platforms, and synergistic lending technologies.
  • We are deploying a unique strategy in the world of private real estate bridge finance, said Ryan Craft, Founder and CEO, Saluda Grade.
  • Founded in 2019, Saluda Grade is a boutique real estate advisory and asset management firm focused on the alternative non-bank lending sector.

Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology

Retrieved on: 
Friday, December 20, 2019

ARTARMON , Australia, Dec. 20, 2019 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announced The Lancet Neurology journal published results from the U.S. Pivotal Study demonstrating its Evoke ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System provided long-term, statistically superior, and clinically meaningful pain relief for patients with chronic intractable back and leg pain out to 12 months compared to open-loop SCS.

Key Points: 
  • ARTARMON , Australia, Dec. 20, 2019 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announced The Lancet Neurology journal published results from the U.S. Pivotal Study demonstrating its Evoke ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System provided long-term, statistically superior, and clinically meaningful pain relief for patients with chronic intractable back and leg pain out to 12 months compared to open-loop SCS.
  • Key results published from the Evoke U.S. Pivotal Study at 12 months include:
    Closed-loop SCS met the pre-specified primary endpoint.
  • The U.S. Evoke pivotal study is the first double-blinded, randomized, controlled U.S. pivotal study in the field of spinal cord stimulation.
  • Saluda Medical is a privately-held company with headquarters in Artarmon,New South Wales, Australiaand offices inBloomington, MN, USA andHarrogate, UK.